Malathion

DB00772ApprovedSmall moleculeCholinesterase Inhibitors

Malathion is a parasympathomimetic organophosphate used to treat head lice. Malathion is an irreversible cholinesterase inhibitor and has low human toxicity.

Chemical structure of Malathion
Mechanism
Curator reviewed
Primary indication
For patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.Curator reviewed · 1 structured indication
Formula / weight
C10H19O6PS2 · 330.358 g/mol (avg)
First approval
United States, 1982
Also known as
Carbophos · Karbofos · Maldison · Mercaptothion
Code names
ENT-17034 · NSC-6524
Brand names
  • Ovide

Resolves to

Structure
InChIKeyJXSJBGJIGXNWCI-UHFFFAOYSA-NSMILESCCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
386Drug interactionsStructured to mechanism, not free text
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
9Marketed productsAcross 3 countries and 7 labellers
Sign in
1ATC codeIncluding every combination product, plus 22 drug categories
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Malathion, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account